We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $2.58M invested in Blueprint Medicines in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 344 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less funds holding

Funds holding: 354 → 5 (-349)

99.54% less ownership

Funds ownership: 99.58% → 0.04% (-100%)

100% less capital invested

Capital invested by funds: $8.24B → $2.58M (-$8.24B)

100% less funds holding in top 10

Funds holding in top 10: 29 → 0 (-29)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 344

Holders
5
Holders Change
-349
Holders Change %
-98.59%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-29
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
344
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$822M
2
BlackRock
BlackRock
New York
-$784M
3
PCM
Pentwater Capital Management
Florida
-$500M
4
State Street
State Street
Massachusetts
-$286M
5
UBS Group
UBS Group
Switzerland
-$278M
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
126
Carmignac Gestion
France
– -$7.01M -54,676 Closed
AA
127
ABC Arbitrage
France
– -$6.75M -52,650 Closed
Adage Capital Partners
128
Adage Capital Partners
Massachusetts
– -$6.41M -50,000 Closed
Canada Pension Plan Investment Board
129
Canada Pension Plan Investment Board
Ontario, Canada
– -$6.33M -49,400 Closed
PHS
130
PFM Health Sciences
California
– -$6.21M -48,444 Closed
CSS
131
Cubist Systematic Strategies
Connecticut
– -$5.97M -46,602 Closed
EAM
132
EFG Asset Management
Oregon
– -$5.88M -45,826 Closed
TCA
133
Taconic Capital Advisors
New York
– -$5.77M -45,000 Closed
YCM
134
Yakira Capital Management
Connecticut
– -$5.68M -44,325 Closed
GL
135
Governors Lane
New York
– -$5.46M -42,566 Closed
Universal-Beteiligungs- und Servicegesellschaft
136
Universal-Beteiligungs- und Servicegesellschaft
Germany
– -$5.33M -41,571 Closed
FIA
137
FNY Investment Advisers
New York
– -$5.26M -41,060 Closed
First Trust Advisors
138
First Trust Advisors
Illinois
– -$5.1M -39,783 Closed
AI
139
Axiom Investors
Connecticut
– -$5.09M -39,676 Closed
MIM
140
MetLife Investment Management
New Jersey
– -$4.89M -38,125 Closed
EIM
141
Essex Investment Management
Massachusetts
– -$4.65M -36,291 Closed
Wells Fargo
142
Wells Fargo
California
– -$4.53M -35,338 Closed
PP
143
PDT Partners
New York
– -$4.39M -34,271 Closed
Russell Investments Group
144
Russell Investments Group
United Kingdom
– -$4.38M -34,201 Closed
WA
145
Waverly Advisors
Alabama
– -$4.35M -33,957 Closed
MOACM
146
Mutual of America Capital Management
New York
– -$4.3M -33,547 Closed
BCM
147
Bayesian Capital Management
New York
– -$4.27M -33,300 Closed
Creative Planning
148
Creative Planning
Kansas
– -$4.21M -32,810 Closed
SF
149
Synovus Financial
Georgia
– -$4.18M -32,572 Closed
Ensign Peak Advisors
150
Ensign Peak Advisors
Utah
– -$4.17M -32,500 Closed
4 5
6
7 8

BPMC Hedge Fund Activity: Q3 2025 in Review

5 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2025, worth a combined $2.58M — down 100% from $8.24B a quarter earlier.

Sellers outnumbered buyers: 344 funds closed out of BPMC and 0 opened new positions — a net loss of 344 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $2.06K. The largest seller was Vanguard Group, exiting entirely with an estimated $822M sold.

  • 5 institutional investors held Blueprint Medicines (BPMC) as of Q3 2025, down from 354 in Q2 2025.
  • Funds reported $2.58M of Blueprint Medicines stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Blueprint Medicines positions in Q3 2025 and 344 closed out, a net change of -344 holders.
  • The largest Blueprint Medicines buyer in Q3 2025 was IFP Advisors, an estimated $2.06K added.
  • The largest Blueprint Medicines seller in Q3 2025 was Vanguard Group, an estimated $822M sold.

Based on aggregated 13F filings for Q3 2025.